Product Recalls in Massachusetts

Product recalls affecting Massachusetts — including food, drugs, consumer products, medical devices, and vehicles distributed to Massachusetts. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,765 recalls have been distributed to Massachusetts in the last 12 months.

52,647 total recalls
2,765 in last 12 months

Showing 761780 of 13,418 recalls

DrugDecember 18, 2024· Alcon Research LLC

Recalled Item: Systane Lubricant Eye Drops Recalled by Alcon Research LLC Due to Non-Sterility

The Issue: Non-Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 18, 2024· Granules Pharmaceuticals Inc.

Recalled Item: Colchicine Capsules 0.6 mg Recalled by Granules Pharmaceuticals Inc. Due to...

The Issue: Failed Dissolution Specifications: Out of specification observed during the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 18, 2024· Eugia US LLC

Recalled Item: medroxyPROGESTERone Acetate Injectable Suspension Recalled by Eugia US LLC...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 18, 2024· AvKARE

Recalled Item: Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing...

The Issue: LABELING: LABEL MIX-UP

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 18, 2024· AvKARE

Recalled Item: Polyvinyl Alcohol Ophthalmic Solution 1.4% Recalled by AvKARE Due to...

The Issue: LABELING: LABEL MIX-UP

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 17, 2024· Amerisource Health Services LLC

Recalled Item: glipiZIDE Recalled by Amerisource Health Services LLC Due to Failed...

The Issue: Failed Dissolution Specifications:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 16, 2024· SHOPPERS- PLAZA

Recalled Item: FOUZEE SugarLin HERBAL FORMULA capsules Recalled by SHOPPERS- PLAZA Due to...

The Issue: Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 16, 2024· FDC Limited

Recalled Item: Ciprofloxacin Ophthalmic Solution USP Recalled by FDC Limited Due to...

The Issue: Defective container: Unable to get the solution out of the bottle as the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 16, 2024· SOMERSET THERAPEUTICS LLC

Recalled Item: Atropine Sulfate Ophthalmic Solution Recalled by SOMERSET THERAPEUTICS LLC...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 13, 2024· Amerisource Health Services LLC

Recalled Item: Clobazam Tablets Recalled by Amerisource Health Services LLC Due to Presence...

The Issue: Presence of Foreign Tablets/Capsules

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Recalled by Akron Pharma, Inc. Due to Labeling: Not Elsewhere...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 25 mg Recalled by Akron Pharma, Inc. Due to Labeling:...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 50 mg Recalled by Akron Pharma, Inc. Due to Labeling:...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Regular Strength Recalled by Akron Pharma, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 25 mg Recalled by Akron Pharma, Inc. Due to Labeling:...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Extra Strength 500 mg Recalled by Akron Pharma, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Extra Strength 500 mg Recalled by Akron Pharma, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Buy-Herbal

Recalled Item: Nhan Sam Tuyet Lien Truy Phong Hoan Recalled by Buy-Herbal Due to Undeclared...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found the products to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 12, 2024· GNMart LLC

Recalled Item: FORCE FOREVER 400mg Tablets Recalled by GNMart LLC Due to Marketed without...

The Issue: Marketed without an approved NDA/ANDA. FDA analysis found the product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 12, 2024· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate Recalled by Ascend Laboratories, LLC Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund